ANAB short interest
AnaptysBio Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 5,236,151 |
|---|---|
| Change vs prior report | -201,287 (-3.7%) |
| Change over six months | +8.8% |
| Days to cover | 8.19 (sector: 3.78) |
| Average daily volume | 639,524 |
| Rank in Healthcare | #191 of 922 by days to cover |
ANAB short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 5,236,151 | -3.7% | 8.19 | 639,524 |
| 2026-09-15 | 5,437,438 | +0.5% | 10.25 | 530,306 |
| 2026-08-31 | 5,412,436 | +1.8% | 15.59 | 347,135 |
| 2026-08-14 | 5,317,981 | -1.6% | 14.29 | 372,089 |
| 2026-07-31 | 5,401,866 | +8.1% | 7.21 | 749,400 |
| 2026-07-15 | 4,999,494 | -2.9% | 5.86 | 853,496 |
| 2026-06-30 | 5,148,302 | +11.2% | 8.27 | 622,514 |
| 2026-06-15 | 4,631,786 | -3.9% | 8.17 | 566,928 |
| 2026-05-29 | 4,821,283 | +0.5% | 9.85 | 489,677 |
| 2026-05-15 | 4,796,235 | +7.5% | 7.26 | 660,958 |
| 2026-04-30 | 4,461,532 | +8.7% | 5.47 | 816,096 |
| 2026-04-15 | 4,106,275 | -14.7% | 7.97 | 515,175 |
| 2026-03-31 | 4,811,520 | +0.4% | 6.93 | 694,335 |
| 2026-03-13 | 4,793,437 | -10.7% | 7.56 | 634,203 |
| 2026-02-27 | 5,366,443 | -4.8% | 17.99 | 298,359 |
| 2026-02-13 | 5,633,784 | -0.6% | 10.07 | 559,392 |
| 2026-01-30 | 5,664,742 | +1.8% | 17.56 | 322,566 |
| 2026-01-15 | 5,566,932 | +8.2% | 8.64 | 644,049 |
| 2025-12-31 | 5,142,551 | -8.9% | 12.15 | 423,212 |
| 2025-12-15 | 5,644,248 | -3.7% | 12.54 | 450,189 |
| 2025-11-28 | 5,863,333 | -1.1% | 8.83 | 663,793 |
| 2025-11-14 | 5,930,320 | -13.4% | 7.21 | 822,231 |
| 2025-10-31 | 6,849,127 | -3.6% | 23.06 | 297,023 |
| 2025-10-15 | 7,105,715 | -0.8% | 15.38 | 462,045 |
| 2025-09-30 | 7,162,596 | -23.9% | 7.93 | 902,894 |
import finzdata as yf
yf.Ticker("ANAB").short_interest # every report since 2017
yf.Client().short_interest(["ANAB"], start="2018-01-01")Healthcare short interest · ANAB price history · Who owns ANAB · All short interest